4-Methylvaleric acid Manufacturer CAS NO.646-07-1
- FOB Price: USD: 10.00-10.00 /Kilogram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
99%(1-99)Kilogram
- Product Details
Keywords
- 4-Methylvaleric acid
- 646-07-1
- isobutylaceticacid
Quick Details
- ProName: 4-Methylvaleric acid Manufacturer
- CasNo: 646-07-1
- Molecular Formula: C6H12O2
- Appearance: colorless liquid
- Application: The product is used for pharmaceutical...
- DeliveryTime: Immediate delivery in stock
- PackAge: 1kg/bottle, 200kg/drum
- Port: Any port
- ProductionCapacity: 10 Metric Ton/Day
- Purity: 99%min
- Storage: In well-closed container, protected f...
- Transportation: by Air, by Sea, by courier (door to do...
- LimitNum: 1 Gram
- Moisture Content: Not more than 1.0%
- Impurity: Not more than 2.0%
Superiority
Advantage :
LIDE PHARMACEUTICALS LIMITED is a professional chemicals and APIs leading manufacturer in China. Our core business line covers APIs, Intermediates, Herb extract, etc.
We are specialized in chemical synthesis, process development of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and rare chemicals. We also accept custom synthesis project and contract research services.
R&D strength:
We have well equipped chemicals and instrumental laboratories with modern instruments such as HPLC,GC,IR,UV,NMR,LC-MS etc.
At present, we are selling it with good discount for immediate delivery ! BOOKING TO HASTEN !
Details
(1) Company profile:
Company profile: Lide pharmaceuticals limited
Main products: APIs; Intermediate and other fine chemical products; Piperazine series; Custom Synthesis.
Main Markets: North America; South America; Eastern Europe; Southeast Asia; Africa Oceania; Mid East; Eastern Asia; Western Europe, etc.
(2) Product:
Product Name: 4-Methylvaleric acid
CAS No.: 646-07-1
Molecular Formula:C6H12O2
Molecular Weight:116.16
Appearance:colorless liquid
Specification: 99%min
(3) Application:
The product is used for pharmaceutical research and development.